Codexis (CDXS) Change in Account Payables (2010 - 2026)
Codexis (CDXS) posted quarterly Change in Account Payables of $312000.0 for Q1 2026, down 84.89% year-over-year from $2.1 million in Q1 2025, and up 139.34% quarter-over-quarter from -$793000.0 in Q4 2025.
Codexis (CDXS) Change in Account Payables (2010 - 2026) Analysis & Trends
Codexis' Change in Account Payables history runs 17 years deep, the most recent figure standing at $312000.0 for Q1 2026.
- In Q1 2026, Change in Account Payables fell 84.89% year-over-year to $312000.0; the TTM figure through Mar 2026 stood at -$3.0 million (down 297.85% YoY), while the FY2025 annual figure was -$1.3 million, up 49.9% from the prior year.
- Change in Account Payables for Q1 2026 stood at $312000.0, up from -$793000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $2.4 million in Q4 2023, with the low at -$3.5 million in Q2 2025.
- The 5-year median for Change in Account Payables is $71000.0 (2022), against an average of -$61588.2.
- The sharpest annual moves came in 2022 and 2025: Change in Account Payables jumped 336.69% in 2022, then tumbled 1361.18% in 2025.
- Codexis' Change in Account Payables stood at $558000.0 in 2022, then surged by 328.67% to $2.4 million in 2023, then tumbled by 151.34% to -$1.2 million in 2024, then soared by 35.42% to -$793000.0 in 2025, then surged by 139.34% to $312000.0 in 2026.
- Business Quant data shows CDXS's Change in Account Payables at $312000.0 in Q1 2026, -$793000.0 in Q4 2025, and $905000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn | 737,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 737,000.00 |
| Jun 30, 2026 | 737,000.00 |
| Mar 31, 2026 | 312,000.00 |
| Mar 31, 2026 | 312,000.00 |
| Dec 31, 2025 | -793,000.00 |
| Dec 31, 2025 | -793,000.00 |
| Sep 30, 2025 | 905,000.00 |
| Sep 30, 2025 | 905,000.00 |
| Jun 30, 2025 | -3.46 Mn |
| Jun 30, 2025 | -3.46 Mn |
| Mar 31, 2025 | 2.07 Mn |
| Mar 31, 2025 | 2.07 Mn |
| Dec 31, 2024 | -1.23 Mn |
| Dec 31, 2024 | -1.23 Mn |
| Sep 30, 2024 | 936,000.00 |
| Sep 30, 2024 | 936,000.00 |
| Jun 30, 2024 | -237,000.00 |
| Jun 30, 2024 | -237,000.00 |
| Mar 31, 2024 | -2.04 Mn |
| Mar 31, 2024 | -2.04 Mn |